NCT04247984 2022-03-11A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerChineseAMSPhase 2 Completed264 enrolled
NCT01529164 2013-11-27Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerChineseAMSPhase 2 Unknown51 enrolled
NCT01679327 2012-09-06Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerChineseAMSPhase 2 Unknown100 enrolled